Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy
The FDA approved Gilead's triple combination treatment for HIV, Biktarvy. Source: BioSpace
The FDA approved Gilead's triple combination treatment for HIV, Biktarvy. Source: BioSpace
Here is some insight on what Vertex may be looking for in their employees. Source: BioSpace
MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace
Joseph E. Payne was shown the door as CEO of Arcturus last week - a move that Payne is not taking lightly. Source: BioSpace
Since Friday, the stock market has been volatile, to say the least. Source: BioSpace
This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace
It's the end of the road for Cambridge, MA based Enumeral Biomedical. Source: BioSpace
Natalizumab did not demonstrate improvement in clinical outcomes compared to placebo. Source: BioSpace
Since Emma Walmsley took over leadership at Glaxo, expectations have been both high and hypercritical. Source: BioSpace
Bexsero is the first vaccine in the world to receive the designation twice. Source: BioSpace